FLC Capital Advisors Sells 333 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

FLC Capital Advisors decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,860 shares of the healthcare conglomerate’s stock after selling 333 shares during the period. FLC Capital Advisors’ holdings in UnitedHealth Group were worth $979,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Keebeck Wealth Management LLC raised its stake in UnitedHealth Group by 11.6% during the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after buying an additional 1,122 shares during the period. Ascension Capital Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $216,000. Physician Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $207,000. Bartlett & Co. LLC raised its stake in shares of UnitedHealth Group by 5.7% in the third quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock worth $82,865,000 after purchasing an additional 8,873 shares during the last quarter. Finally, Great Valley Advisor Group Inc. raised its stake in shares of UnitedHealth Group by 5.8% in the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after purchasing an additional 1,884 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $0.83 on Wednesday, reaching $493.14. The company’s stock had a trading volume of 2,653,123 shares, compared to its average volume of 4,102,408. The stock’s 50 day simple moving average is $503.73 and its 200-day simple moving average is $518.79. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $454.64 billion, a P/E ratio of 20.66, a PEG ratio of 1.32 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same quarter last year, the business posted $5.34 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler reduced their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. HSBC reissued a “reduce” rating and set a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Finally, Truist Financial reissued a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Thursday, November 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.